Hematology / Oncology @Point of Care Podcasts Podcast Por @Point of Care arte de portada

Hematology / Oncology @Point of Care Podcasts

Hematology / Oncology @Point of Care Podcasts

De: @Point of Care
Escúchala gratis

Acerca de esta escucha

 Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.Copyright 2020 At Point of Care, LLC. All rights reserved. Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts

    S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts
    May 31 2025

    In this episode, our Faculty, Dr. Charu Aggarwal and Dr. Jacob Sands, explore the clinical impact of investigational TROP2-directed antibody-drug conjugates (ADCs), their safety profile, and expert strategies for managing potential toxicities.

    Visit https://suitehome.atpointofcare.com/library/2674.03/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    Más Menos
    26 m
  • S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies

    S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies
    May 31 2025

    In this episode, our Faculty, Dr. Charu Aggarwal and Dr. Jacob Sands, discuss ongoing clinical trials, evolving biomarker approaches using Quantitative Continuous Scoring (QCS), and the future of personalized care in lung cancer.

    Visit https://suitehome.atpointofcare.com/library/2674.02/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    Más Menos
    26 m
  • S22:E1 – TROP2-directed ADCs in the Second Line: Updates from Clinical Trials in NSCLC

    S22:E1 – TROP2-directed ADCs in the Second Line: Updates from Clinical Trials in NSCLC
    May 31 2025

    In this episode, our Faculty, Dr. Charu Aggarwal and Dr. Jacob Sands, explore the evolving landscape of TROP2-directed antibody-drug conjugates in second-line NSCLC treatment. Hear their expert insights on recent clinical trial updates and what these findings mean for treatment sequencing, biomarker-driven care, and the future of NSCLC management. Visit https://suitehome.atpointofcare.com/library/2674.01/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    Más Menos
    28 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones